Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyarticular Juvenile Rheumatoid Arthritis”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Large-scale testing (Phase 3)Study completedNCT02592434
What this trial is testing

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Who this might be right for
Juvenile Idiopathic Arthritis
Pfizer 225
Large-scale testing (Phase 3)Study completedNCT00048542
What this trial is testing

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Arthritis, Juvenile Idiopathic
Abbott 171
Large-scale testing (Phase 3)Study completedNCT00144625
What this trial is testing

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Polyarticular Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Not applicableStudy completedNCT02593006
What this trial is testing

Start Time Optimization of Biologics in Polyarticular JIA

Who this might be right for
Polyarticular Juvenile Rheumatoid ArthritisArthritis, Juvenile Idiopathic
Hackensack Meridian Health 400
Early research (Phase 1)Looking for participantsNCT07184450
What this trial is testing

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Who this might be right for
Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)+1 more
Chongqing Precision Biotech Co., Ltd 11
Large-scale testing (Phase 3)Study completedNCT01673919
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 7
Large-scale testing (Phase 3)Looking for participantsNCT06654882
What this trial is testing

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Who this might be right for
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University 400
Testing effectiveness (Phase 2)Study completedNCT02776735
What this trial is testing

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 102
Testing effectiveness (Phase 2)WithdrawnNCT06623240
What this trial is testing

HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Hope Biosciences Research Foundation
Large-scale testing (Phase 3)Study completedNCT01835470
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 23
Large-scale testing (Phase 3)Study completedNCT00144664
What this trial is testing

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Large-scale testing (Phase 3)Study completedNCT00690573
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Abbott 25
Testing effectiveness (Phase 2)Study completedNCT00037648
What this trial is testing

Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Chronic Arthritis
Amgen 86
Large-scale testing (Phase 3)Ended earlyNCT03781375
What this trial is testing

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 25
Not applicableStudy completedNCT01304420
What this trial is testing

Ultrasonography in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis, OligoarthritisPolyarticular Juvenile Rheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis
University of Aarhus 95
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableEnded earlyNCT01557452
What this trial is testing

Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Italfarmaco 1
Early research (Phase 1)Study completedNCT01904279
What this trial is testing

Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 52
Next Page